This article was generated by an automated content engine and was reviewed by a human editor prior to publication. For additional information, read Cocrystal Pharma’s 8K filing here.
Cocrystal Pharma Company Profile
Cocrystal Pharma, Inc, a biotechnology company, focuses on the discovery and development of antiviral therapeutic treatments for serious and/or chronic viral diseases. It employs structure-based technologies to create antiviral drugs primarily to treat hepatitis C virus (HCV), influenza virus, coronavirus, norovirus, and respiratory virus infections.
Further Reading
- Five stocks we like better than Cocrystal Pharma
- What Does a Stock Split Mean?
- How Whitestone REIT Is Transforming Sun Belt Retail Growth
- The Most Important Warren Buffett Stock for Investors: His Own
- Top-Performing Non-Leveraged ETFs This Year
- 2 Fintech Stocks to Buy Now and 1 to Avoid
- Rivian’s Wild Ride: Is the Dip a Buying Opportunity?
